SPEAKERS

Scientific Advisory Committee

Bo Ying

Chief Executive Officer

AboGen Inc.

Kevin Kee-Jong Hong

Professor

Gachon University

Biophama & Academic Leaders

Adam zhao

Chief Executive Officer

AnlongBio

Elle Li

R&D Director

Innorna Co. Ltd

Hayato Watanabe

President & Chief Executive Officer

Crafton Biotechnology

Hyukjin Lee

Professor

Seoul National University

Jaehyun Choi

Chief Executive Officer & Head of R&D

Genexine, Inc.

June Kim

CMC Lead

CEPI

Madhavan Nallani

Founder & Chief Executive Officer

ACM Biosciences

Norihiko Shiraishi

Executive Officer, Chief Scientific Officer & mRNA IPG Unit Head

NANO MRNA Co., Ltd.

Pengbo Guo

Partner

CybernaX Bio

Rongkuan Frank Hu

Chief Executive Officer

Starna therapeutics

Sang Hwan Seo

Director

International Vaccine Institute (IVI)

Sunghoon Ma

Head of the Medicine Discovery & Development Division

GC Pharma

Swarnendu Kaviraj

Associate Director of R&D

Gennova Biopharma Limited

Wonil Kim

Chief Scientific Officer

Aston Science Inc

Xian Zeng

Chief Executive Officer & Co-Founder

Byterna Therapeutics

Xiangrong Song

Chief Executive Officer & Co-Founder

WestGene Biopharma

Xueliang Yu

Vice President

Starna Therapeutics

Yaoqi Zhou

Professor

Shenzen Bay Laboratory

Yasumasa Ota

mRNA technology Leader

Meiji Seika Pharma

Yeong-Chan Ahn

Business Development Director

sml biopharm

Yi Yan Yang

Distinguished Principal Scientist

Agency for Science, Technology and Research (A*STAR)

Yu Pang

Senior Scientist

Pfizer

Solution Experts

Josephine Cheng

Senior Modality Leader RNA Therapeutics – Asia Pacific excl. China (APeC)

Merck KGaA

Nelli Erwin

Global Strategic Product Manager – Downstream Chemicals & mRNA Enzymes

Merck KGaA

Shigeki Miyake-Stoner - 4th Circular Self-Amplifying RNA Therapeutics Summit 2025

Shigetomo Tsujihata

General Manager

Fujifilm Corp.